Related Experiment Video
Updated: Aug 13, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Regulation of interleukin-1beta -induced platelet-derived growth factor receptor-alpha expression in rat pulmonary
1Laboratory of Pulmonary Pathobiology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
Abstract:
The potential role of p38 mitogen-activated protein (MAP) kinase in platelet-derived growth factor receptor-alpha (PDGF-Ralpha) gene expression was investigated using cultured rat pulmonary myofibroblasts. p38 MAP kinase was constitutively expressed in myofibroblasts and activated by interleukin (IL)-1beta. A pyridinylimidazole compound, SB203580, completely inhibited the ability of p38 MAP kinase activity to phosphorylate PHAS-1 substrate. SB203580 inhibited IL-1beta-induced up-regulation of PDGF-Ralpha mRNA and protein in a concentration-dependent manner. Other kinase inhibitors, including the mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor PD98059, did not block up-regulation of PDGF-Ralpha. The IL-1beta-induced increase in the number of (125)I-PDGF-AA-binding sites at the cell surface was reduced >70% by pretreatment with SB203580. Accordingly, an enhancement of PDGF-AA-stimulated DNA synthesis following IL-1beta pretreatment was blocked >70% by SB203580. SB203580 did not affect IL-1beta-induced ERK activation, yet enhanced IL-1beta-induced JNK activation approximately 2-fold. Treatment of cells with SB203580 after inhibition of transcription by actinomycin D decreased the half-life of IL-1beta-induced PDGF-Ralpha mRNA from >4 to approximately 1.5 h. Moreover, pretreatment of cells with cycloheximide blocked induction of PDGF-Ralpha mRNA by IL-1beta, suggesting that de novo protein synthesis was required for PDGF-Ralpha mRNA stabilization. These data indicate that p38 MAP kinase regulates PDGF-Ralpha expression at the translational level by signaling the synthesis of an mRNA-stabilizing protein.
Insights
p38 mitogen-activated protein (MAP) kinase regulates platelet-derived growth factor receptor-alpha (PDGF-Ralpha) expression. It signals the synthesis of an mRNA-stabilizing protein, impacting PDGF-Ralpha levels and cell growth.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- Platelet-derived growth factor receptor-alpha (PDGF-Ralpha) plays a crucial role in cell proliferation and is implicated in various fibrotic diseases.
- Interleukin-1beta (IL-1beta) is a pro-inflammatory cytokine known to influence gene expression in various cell types.
Purpose of the Study:
- To investigate the role of p38 mitogen-activated protein (MAP) kinase in the regulation of PDGF-Ralpha gene expression in rat pulmonary myofibroblasts.
- To elucidate the molecular mechanisms by which p38 MAP kinase influences PDGF-Ralpha expression.
Main Methods:
- Primary rat pulmonary myofibroblasts were cultured and treated with IL-1beta.
- p38 MAP kinase activity was inhibited using the specific inhibitor SB203580.
- PDGF-Ralpha mRNA and protein levels were quantified using RT-PCR and Western blotting.
- Cell surface binding of PDGF-AA and PDGF-AA-stimulated DNA synthesis were assessed.
- mRNA stability was evaluated using actinomycin D, and protein synthesis requirement was tested with cycloheximide.
Main Results:
- p38 MAP kinase was constitutively expressed and activated by IL-1beta in myofibroblasts.
- SB203580 inhibited IL-1beta-induced upregulation of PDGF-Ralpha mRNA and protein in a dose-dependent manner.
- SB203580 significantly reduced PDGF-AA binding sites and blocked PDGF-AA-stimulated DNA synthesis.
- p38 MAP kinase inhibition stabilized PDGF-Ralpha mRNA, indicating regulation at the translational level.
- De novo protein synthesis was required for PDGF-Ralpha mRNA stabilization.
Conclusions:
- p38 MAP kinase plays a critical role in regulating PDGF-Ralpha expression in pulmonary myofibroblasts.
- The mechanism involves signaling the synthesis of an mRNA-stabilizing protein, affecting PDGF-Ralpha mRNA stability.
- These findings highlight p38 MAP kinase as a potential therapeutic target for conditions involving PDGF-Ralpha dysregulation.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

